Dr. Amy S. Anstead, MD

Dr. Anstead practices at Eye Clinic of Edmonds - HOPD in Edmonds, Washington.

Dr. Anstead's NPI, 1982852448, was assigned on September 8, 2008. Dr. Anstead graduated from University of Miami, Miller School of Medicine in 2004. Dr. Anstead holds Washington license MD60164627.

Dr. Anstead's primary practice is Eye Clinic of Edmonds - HOPD, at 21911 76th Ave W, Edmonds, WA 98026.

Dr. Anstead's primary practice is Eye Clinic of Edmonds - HOPD in Edmonds, Washington. Dr. Anstead is also affiliated with Providence Swedish Edmonds Campus. The medical group on file is Seattle Orthopedic Center. Dmand AI also links Dr. Anstead to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Anstead practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Anstead's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Anstead is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Anstead's licenses on file in 3 states: Washington, Florida and Illinois.

Dmand AI lists chronic nasal allergies, chronic sinusitis and endoscopic sinus surgery among the conditions Dr. Anstead treats.

CMS data shows 720 Medicare services from Dr. Anstead across 12 procedure codes in 2024, for 113 Medicare patients. Medicare paid $120,283 for them.

CMS counts 113 Medicare patients who saw Dr. Anstead in 2024. The largest group is 65 to 74, with 64 patients. 74% of them have high cholesterol, and 61% have high blood pressure. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Anstead's median patient age at 55, with 54% women.

In 2024, Dr. Anstead wrote 481 Medicare Part D claims for 113 patients. 94% of them were for generic drugs. CMS names the drug for 377 of them, across 12 drugs with 11 or more claims each, at $69,129 in total drug cost.

Dr. Anstead accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Anstead, published from 2009 to 2013. 2011 was the busiest year, with 2. The most frequent topics are Endoscopy. Dr. Anstead has published most often in Int J Pediatr Otorhinolaryngol. Dr. Anstead's most frequent co-authors are Adam J. Folbe, MD, Belachew Tessema, MD and Roy R. Casiano, MD.

CMS Open Payments shows 4 general payments to Dr. Anstead from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $283.

Dmand AI lists 1 award for Dr. Anstead.

Dr. Anstead graduated from University of Miami, Miller School of Medicine in 2004.

Dr. Anstead is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.